Reviews Afluria


No reviews yet.

Afluria Drug Description
AFLURIA®
Influenza Virus Vaccine Suspension for Intramuscular Injection 2007-2008 Formula
DRUG DESCRIPTION



What are the possible side effects of influenza virus injectable vaccine?

Influenza virus injectable (killed virus) vaccine will not cause you to become ill with the flu virus that it contains. However, you may have flu-like symptoms at any time during flu season that may be caused by other strains of influenza virus.
You should not receive a booster vaccine if you had a life-threatening allergic reaction after the first shot.
Keep track of any and all side effects you have after receiving this vaccine. If you ever have to receive another influenza virus...
Read All Potential Side Effects for Afluria »




AFLURIA®, Influenza Virus Vaccine for intramuscular injection, is a sterile, clear, colorless to slightly opalescent suspension with some sediment that resuspends upon shaking to form a homogeneous suspension. AFLURIA® is prepared from influenza virus propagated in the allantoic fluid of embryonated chicken eggs. Following harvest, the virus is purified in a sucrose density gradient using a continuous flow zonal centrifuge. The purified virus is inactivated with beta-propiolactone, and the virus particles are disrupted using sodium taurodeoxycholate to produce a “split virion”. The disrupted virus is further purified and suspended in a phosphate buffered isotonic solution.
AFLURIA® is standardized according to USPHS requirements for the 2007-2008 influenza season and is formulated to contain 45 mcg HA per 0.5 mL dose in the recommended ratio of 15 mcg HA for each of the three influenza strains recommended for the 2007-2008 Northern Hemisphere influenza season: A/H1N1 (A/Solomon Islands/3/2006), A/H3N2 (A/Wisconsin/67/2005), and influenza B (B/Malaysia/2506/2004).
The single-dose formulation is preservative-free; thimerosal, a mercury derivative, is not used in the manufacturing process for this formulation. The multi-dose formulation contains thimerosal, added as a preservative; each 0.5 mL dose contains 24.5 mcg of mercury.
A single 0.5 mL dose of AFLURIA® contains sodium chloride (4.1 mg), monobasic sodium phosphate (80 mcg), dibasic sodium phosphate (300 mcg), monobasic potassium phosphate (20 mcg), potassium chloride (20 mcg), and calcium chloride (1.5 mcg). From the manufacturing process, each dose may also contain residual amounts of sodium taurodeoxycholate ( ≤ 10 ppm), ovalbumin ( ≤ 0.10 mcg), neomycin sulfate ( ≤ 0.2 picograms [pg]), polymyxin B ( ≤ 0.03 pg), and beta-propiolactone ( < 25 nanograms).
The rubber tip cap and plunger used for the preservative-free, single-dose syringes and the rubber stoppers used for the multi-dose vial contain no latex.
Last reviewed on RxList: 11/26/2007




Afluria Drug Description
AFLURIA®
Influenza Virus Vaccine Suspension for Intramuscular Injection 2007-2008 Formula
DRUG DESCRIPTION



What are the possible side effects of influenza virus injectable vaccine?

Influenza virus injectable (killed virus) vaccine will not cause you to become ill with the flu virus that it contains. However, you may have flu-like symptoms at any time during flu season that may be caused by other strains of influenza virus.
You should not receive a booster vaccine if you had a life-threatening allergic reaction after the first shot.
Keep track of any and all side effects you have after receiving this vaccine. If you ever have to receive another influenza virus...
Read All Potential Side Effects for Afluria »




AFLURIA®, Influenza Virus Vaccine for intramuscular injection, is a sterile, clear, colorless to slightly opalescent suspension with some sediment that resuspends upon shaking to form a homogeneous suspension. AFLURIA® is prepared from influenza virus propagated in the allantoic fluid of embryonated chicken eggs. Following harvest, the virus is purified in a sucrose density gradient using a continuous flow zonal centrifuge. The purified virus is inactivated with beta-propiolactone, and the virus particles are disrupted using sodium taurodeoxycholate to produce a “split virion”. The disrupted virus is further purified and suspended in a phosphate buffered isotonic solution.
AFLURIA® is standardized according to USPHS requirements for the 2007-2008 influenza season and is formulated to contain 45 mcg HA per 0.5 mL dose in the recommended ratio of 15 mcg HA for each of the three influenza strains recommended for the 2007-2008 Northern Hemisphere influenza season: A/H1N1 (A/Solomon Islands/3/2006), A/H3N2 (A/Wisconsin/67/2005), and influenza B (B/Malaysia/2506/2004).
The single-dose formulation is preservative-free; thimerosal, a mercury derivative, is not used in the manufacturing process for this formulation. The multi-dose formulation contains thimerosal, added as a preservative; each 0.5 mL dose contains 24.5 mcg of mercury.
A single 0.5 mL dose of AFLURIA® contains sodium chloride (4.1 mg), monobasic sodium phosphate (80 mcg), dibasic sodium phosphate (300 mcg), monobasic potassium phosphate (20 mcg), potassium chloride (20 mcg), and calcium chloride (1.5 mcg). From the manufacturing process, each dose may also contain residual amounts of sodium taurodeoxycholate ( ≤ 10 ppm), ovalbumin ( ≤ 0.10 mcg), neomycin sulfate ( ≤ 0.2 picograms [pg]), polymyxin B ( ≤ 0.03 pg), and beta-propiolactone ( < 25 nanograms).
The rubber tip cap and plunger used for the preservative-free, single-dose syringes and the rubber stoppers used for the multi-dose vial contain no latex.
Last reviewed on RxList: 11/26/2007




Afluria Drug Description
AFLURIA®
Influenza Virus Vaccine Suspension for Intramuscular Injection 2007-2008 Formula
DRUG DESCRIPTION



What are the possible side effects of influenza virus injectable vaccine?

Influenza virus injectable (killed virus) vaccine will not cause you to become ill with the flu virus that it contains. However, you may have flu-like symptoms at any time during flu season that may be caused by other strains of influenza virus.
You should not receive a booster vaccine if you had a life-threatening allergic reaction after the first shot.
Keep track of any and all side effects you have after receiving this vaccine. If you ever have to receive another influenza virus...
Read All Potential Side Effects for Afluria »




AFLURIA®, Influenza Virus Vaccine for intramuscular injection, is a sterile, clear, colorless to slightly opalescent suspension with some sediment that resuspends upon shaking to form a homogeneous suspension. AFLURIA® is prepared from influenza virus propagated in the allantoic fluid of embryonated chicken eggs. Following harvest, the virus is purified in a sucrose density gradient using a continuous flow zonal centrifuge. The purified virus is inactivated with beta-propiolactone, and the virus particles are disrupted using sodium taurodeoxycholate to produce a “split virion”. The disrupted virus is further purified and suspended in a phosphate buffered isotonic solution.
AFLURIA® is standardized according to USPHS requirements for the 2007-2008 influenza season and is formulated to contain 45 mcg HA per 0.5 mL dose in the recommended ratio of 15 mcg HA for each of the three influenza strains recommended for the 2007-2008 Northern Hemisphere influenza season: A/H1N1 (A/Solomon Islands/3/2006), A/H3N2 (A/Wisconsin/67/2005), and influenza B (B/Malaysia/2506/2004).
The single-dose formulation is preservative-free; thimerosal, a mercury derivative, is not used in the manufacturing process for this formulation. The multi-dose formulation contains thimerosal, added as a preservative; each 0.5 mL dose contains 24.5 mcg of mercury.
A single 0.5 mL dose of AFLURIA® contains sodium chloride (4.1 mg), monobasic sodium phosphate (80 mcg), dibasic sodium phosphate (300 mcg), monobasic potassium phosphate (20 mcg), potassium chloride (20 mcg), and calcium chloride (1.5 mcg). From the manufacturing process, each dose may also contain residual amounts of sodium taurodeoxycholate ( ≤ 10 ppm), ovalbumin ( ≤ 0.10 mcg), neomycin sulfate ( ≤ 0.2 picograms [pg]), polymyxin B ( ≤ 0.03 pg), and beta-propiolactone ( < 25 nanograms).
The rubber tip cap and plunger used for the preservative-free, single-dose syringes and the rubber stoppers used for the multi-dose vial contain no latex.
Last reviewed on RxList: 11/26/2007




Afluria Drug Description
AFLURIA®
Influenza Virus Vaccine Suspension for Intramuscular Injection 2007-2008 Formula
DRUG DESCRIPTION



What are the possible side effects of influenza virus injectable vaccine?

Influenza virus injectable (killed virus) vaccine will not cause you to become ill with the flu virus that it contains. However, you may have flu-like symptoms at any time during flu season that may be caused by other strains of influenza virus.
You should not receive a booster vaccine if you had a life-threatening allergic reaction after the first shot.
Keep track of any and all side effects you have after receiving this vaccine. If you ever have to receive another influenza virus...
Read All Potential Side Effects for Afluria »




AFLURIA®, Influenza Virus Vaccine for intramuscular injection, is a sterile, clear, colorless to slightly opalescent suspension with some sediment that resuspends upon shaking to form a homogeneous suspension. AFLURIA® is prepared from influenza virus propagated in the allantoic fluid of embryonated chicken eggs. Following harvest, the virus is purified in a sucrose density gradient using a continuous flow zonal centrifuge. The purified virus is inactivated with beta-propiolactone, and the virus particles are disrupted using sodium taurodeoxycholate to produce a “split virion”. The disrupted virus is further purified and suspended in a phosphate buffered isotonic solution.
AFLURIA® is standardized according to USPHS requirements for the 2007-2008 influenza season and is formulated to contain 45 mcg HA per 0.5 mL dose in the recommended ratio of 15 mcg HA for each of the three influenza strains recommended for the 2007-2008 Northern Hemisphere influenza season: A/H1N1 (A/Solomon Islands/3/2006), A/H3N2 (A/Wisconsin/67/2005), and influenza B (B/Malaysia/2506/2004).
The single-dose formulation is preservative-free; thimerosal, a mercury derivative, is not used in the manufacturing process for this formulation. The multi-dose formulation contains thimerosal, added as a preservative; each 0.5 mL dose contains 24.5 mcg of mercury.
A single 0.5 mL dose of AFLURIA® contains sodium chloride (4.1 mg), monobasic sodium phosphate (80 mcg), dibasic sodium phosphate (300 mcg), monobasic potassium phosphate (20 mcg), potassium chloride (20 mcg), and calcium chloride (1.5 mcg). From the manufacturing process, each dose may also contain residual amounts of sodium taurodeoxycholate ( ≤ 10 ppm), ovalbumin ( ≤ 0.10 mcg), neomycin sulfate ( ≤ 0.2 picograms [pg]), polymyxin B ( ≤ 0.03 pg), and beta-propiolactone ( < 25 nanograms).
The rubber tip cap and plunger used for the preservative-free, single-dose syringes and the rubber stoppers used for the multi-dose vial contain no latex.
Last reviewed on RxList: 11/26/2007




Afluria Drug Description
AFLURIA®
Influenza Virus Vaccine Suspension for Intramuscular Injection 2007-2008 Formula
DRUG DESCRIPTION



What are the possible side effects of influenza virus injectable vaccine?

Influenza virus injectable (killed virus) vaccine will not cause you to become ill with the flu virus that it contains. However, you may have flu-like symptoms at any time during flu season that may be caused by other strains of influenza virus.
You should not receive a booster vaccine if you had a life-threatening allergic reaction after the first shot.
Keep track of any and all side effects you have after receiving this vaccine. If you ever have to receive another influenza virus...
Read All Potential Side Effects for Afluria »




AFLURIA®, Influenza Virus Vaccine for intramuscular injection, is a sterile, clear, colorless to slightly opalescent suspension with some sediment that resuspends upon shaking to form a homogeneous suspension. AFLURIA® is prepared from influenza virus propagated in the allantoic fluid of embryonated chicken eggs. Following harvest, the virus is purified in a sucrose density gradient using a continuous flow zonal centrifuge. The purified virus is inactivated with beta-propiolactone, and the virus particles are disrupted using sodium taurodeoxycholate to produce a “split virion”. The disrupted virus is further purified and suspended in a phosphate buffered isotonic solution.
AFLURIA® is standardized according to USPHS requirements for the 2007-2008 influenza season and is formulated to contain 45 mcg HA per 0.5 mL dose in the recommended ratio of 15 mcg HA for each of the three influenza strains recommended for the 2007-2008 Northern Hemisphere influenza season: A/H1N1 (A/Solomon Islands/3/2006), A/H3N2 (A/Wisconsin/67/2005), and influenza B (B/Malaysia/2506/2004).
The single-dose formulation is preservative-free; thimerosal, a mercury derivative, is not used in the manufacturing process for this formulation. The multi-dose formulation contains thimerosal, added as a preservative; each 0.5 mL dose contains 24.5 mcg of mercury.
A single 0.5 mL dose of AFLURIA® contains sodium chloride (4.1 mg), monobasic sodium phosphate (80 mcg), dibasic sodium phosphate (300 mcg), monobasic potassium phosphate (20 mcg), potassium chloride (20 mcg), and calcium chloride (1.5 mcg). From the manufacturing process, each dose may also contain residual amounts of sodium taurodeoxycholate ( ≤ 10 ppm), ovalbumin ( ≤ 0.10 mcg), neomycin sulfate ( ≤ 0.2 picograms [pg]), polymyxin B ( ≤ 0.03 pg), and beta-propiolactone ( < 25 nanograms).
The rubber tip cap and plunger used for the preservative-free, single-dose syringes and the rubber stoppers used for the multi-dose vial contain no latex.
Last reviewed on RxList: 11/26/2007





Other reviews about Afluria on wordpress

US FDA approves new influenza types A and B vaccine
  by Bishor
Afluria,  a vaccine against seasonal influenza types A and B for people ages 18 and older, was approved using FDA’s accelerated approval pathway for serious or life-threatening diseases, which […]


H1N1 Swine Flu Vaccine Package Insert, Warnings
  by debstake
Thanks to my friend ahrcanum for forwarding this information to me. DEB ==================================================================================================== H1N1 Swine Flu Vaccine Package Insert, Warnings September 27, 2009 by ahrcanum The U.S. Government has evaluated only these vaccines that are […]


Mercury Free Swine Flu Vaccine Available
  by stevensponaugle
If you are required to recieve the Swine Flu Vaccine, by your employer, at least demand one of the mercury free versions below. http://www.injuryboard.com/national-news/will-swine-flu-vaccine-be-hurt-over-thimerosal.aspx?googleid=269222 Posted by Craig The H1N1 vaccines, as […]


Stay away from Thimerosol
  by Obambi.com
14 of the 28 flu vaccines ("seasonal" & "swine") being pushed on us have a form of Mercury known as Thimerosol. Have you taken one or […]


Flu Vaccine for Upcoming Season Approved
  by nalonsospc
FRIDAY, July 30 (HealthDay News) -- The annual flu vaccine for the 2010-2011 influenza season has been approved by the U.S. Food and Drug Administration, the agency said […]


Flu Vaccine for Upcoming Season Approved
  by nalonsospc
FRIDAY, July 30 (HealthDay News) -- The annual flu vaccine for the 2010-2011 influenza season has been approved by the U.S. Food and Drug Administration, the agency said […]


Advisory comittee to CDC recommends not using Australian flu vaccine
  by Skepdude
The Advisory Committee on Immunization Practices, an advisory to the Centers for Disease Control and Prevention, is recommending that the Australian flu vaccine Fluvax (double-check the brand name, […]


ALERT: CDC Advisory: Avoid Fluarix in Kids Under 9 Years
  by Dr. Craig Stern
The Centers for Disease Control and Prevention on Friday recommended against the use of CSL Limited's U.S.-licensed influenza vaccine, Afluria, in children under age 9 […]


U.S. Flu Shots on Hold After Probe ...
  by IV-7
U.S. Flu Shots on Hold after Probe Into Australian Ban on Vaccine for Children Thursday, July 15, 2010 U.S. health authorities […]


Anti Vaccine Watch
  by Skepdude
The anti vaccine movement has been gaining a lot of strength over the past decade, not only in the US, but also worldwide. Parents, celebrities and other interested […]



Other reviews about Afluria on web:

MerckVaccines.com is your place to get information about Merck vaccines. Product Information at MerckVaccines.com


Afluria (influenza virus vaccine) is a vaccine used to prevent infection caused by influenza virus. Includes Afluria side effects, interactions and indications. Afluria Information from Drugs.com


Learn about the prescription medication Afluria (Influenza Virus Vaccine), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Afluria (Influenza Virus Vaccine) Drug Information: Uses, Side ...


All about Afluria. View complete and up to date Afluria information - part of the Drugs.com trusted medication database. Afluria Facts and Comparisons at Drugs.com


Learn about Afluria®’s clinical safety data and for more information see the prescribing information. Afluria® Clinical Safety Data and Clinical Trial Information


Resources for You. Influenza Virus Vaccine Composition and Lot Release Licensed Biological Products with Supporting Documents -- AFLURIA


CSL Biotherapies, and its parent company, CSL Limited have reached an agreement with Merck & Co., Inc. on rights to market and distribute Afluria ® in the United States under an ... Privacy Policy


AFLURIA (Influenza vaccine) drug information for Immunization, Influenza~vaccines from MPR including side effects, drug interactions, dosing, contraindications and warnings ... AFLURIA (Influenza vaccine) drug information from MPR


Afluria influenza virus vaccine, a Merck/CSL product, is indicated for immunization of persons 6 months and older. Afluria information provided by My Flu Vaccine. Afluria - Influenza Virus Vaccine


Learn about Afluria from the publishers of the Physicians Desk Reference. Find prescription drug information resources including interactions, side effects, symptoms, treatment ... Afluria | Prescription Drug Information, Side Effects | PDRHealth





Featured Reviews

Reviews Ringers in Dextrose

Ringers in Dextrose Drug Description Ringer's and 5% Dextrose Injection, USP in AVIVA Plastic Container DRUG DESCRIPTION Ringer's and 5% Dextrose Injection, USP is sterile, nonpyrogenic solution for fluid and electrolyte replenishment...
Read More  |  Review This
Reviews Doral

Doral Drug Description DORAL® (quazepam) Tablets DRUG DESCRIPTION What are the possible side effects of quazepam (Doral)? Quazepam may cause a severe allergic reaction. Stop taking quazepam and get emergency medical help if...
Read More  |  Review This
Reviews Teniposide

Vumon Drug Description VUMON® (teniposide) Injection Formerly: VUMON® (teniposide) For Injection Concentrate WARNING VUMON (teniposide injection) is a cytotoxic drug which should be administered under the supervision of a qualified...
Read More  |  Review This
Reviews Precose

Precose Drug Description PRECOSE® (acarbose) Tablets DRUG DESCRIPTION What are the possible side effects of acarbose (Precose)? Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty...
Read More  |  Review This
Reviews Endrate

Endrate Drug Description ENDRATE (edetate disodium) Anhydrous Injection, Solution FOR INTRAVENOUS INFUSION ONLY AFTER DILUTION Ampul WARNING The use of this drug in any particular patient is recommended only when the severity...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....